Biosynthesis of interleukin-6, an autocrine growth factor for melanoma, is regulated by melanoma-derived histamine

Semin Cancer Biol. 2000 Feb;10(1):25-8. doi: 10.1006/scbi.2000.0304.

Abstract

Interleukin-6 is an autocrine growth factor in advanced stage melanoma and biosynthesis of IL-6 is increased by histamine in various cell lines. In our study we analysed the direct relation of histamine and IL-6 synthesis in human melanoma cell lines. All melanoma cells contained IL-6 mRNA, but only metastatic melanoma cells secreted the IL-6 protein. The H1 histamine receptor antagonist triprolidine decreased gene expression and biosynthesis of IL-6, while other histamine receptor antagonists had no effect. These data indicate that endogenous histamine has a definite role in the regulation of local IL-6, suggesting that histamine and IL-6 could be part of autocrine growth regulation of the tumor.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Glucose-6-Phosphate Isomerase / metabolism*
  • Growth Substances / metabolism*
  • Histamine / metabolism*
  • Histamine / therapeutic use
  • Humans
  • Interleukin-6 / biosynthesis*
  • Melanoma / metabolism*
  • RNA, Messenger / metabolism

Substances

  • Growth Substances
  • Interleukin-6
  • RNA, Messenger
  • Histamine
  • Glucose-6-Phosphate Isomerase